SCHEMBL22907992

SCHEMBL22907992

c1ccc(-c2ccc(-c3ccc(-c4c5ccccc5c(-c5ccc6oc7cc8ccccc8cc7c6c5)c5ccccc45)cc3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 6/20 0.45
ESR2 Q92731 6/20 0.45
PLA2G2A P14555 3/20 0.42
PLA2G4A P47712 3/20 0.42
KDM4E B2RXH2 4/20 0.39
HPGD P15428 4/20 0.39
MAPT P10636 3/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
GLA P06280 2/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 3/20 0.38
AHR P35869 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16067652 1.00 ESR1 (0.45) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL31747799 1.00 ESR1 (0.45) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL22218849 0.98 ESR1 (0.44) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL29416710 0.98 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL16067563 0.98 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL30448082 0.98 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL29511654 0.98 ESR1 (0.46) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL16067702 0.97 PLA2G2A (0.46) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL22217827 0.97 ESR1 (0.45) ESR1ESR2PLA2G2APLA2G4AKDM4E
SCHEMBL25667899 0.97 PLA2G2A (0.46) ESR1ESR2PLA2G2APLA2G4AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 US disclosed
US-11839148-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-12-05 US disclosed
US-20230209996-A1 ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-29 US disclosed
US-20230209998-A1 ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-29 US disclosed
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 ESR1 3/4885ESR2 6/4885PLA2G2A 3402/4885
US-20210020842-A1 ORGANIC LIGHT-EMITTING DEVICE OR10J3, OR51E2, LOXL1 ESR1 132/4885ESR2 264/4885PLA2G2A 2426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.